ArticleJournal of thrombosis and haemostasis : JTH2023

Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cells.

Weiqing Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.